<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0335">
 <label>67</label>
 <element-citation publication-type="journal" id="sbref0335">
  <person-group person-group-type="author">
   <name>
    <surname>Stephenson</surname>
    <given-names>C.M.</given-names>
   </name>
   <name>
    <surname>Levin</surname>
    <given-names>R.D.</given-names>
   </name>
   <name>
    <surname>Spector</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Lis</surname>
    <given-names>C.G.</given-names>
   </name>
  </person-group>
  <article-title>Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer</article-title>
  <source>Cancer chemotherapy and pharmacology.</source>
  <volume>72</volume>
  <issue>1</issue>
  <year>2013</year>
  <fpage>139</fpage>
  <lpage>146</lpage>
  <pub-id pub-id-type="pmid">23670640</pub-id>
 </element-citation>
</ref>
